Literature DB >> 11606111

Ovarian conservation in a woman of reproductive age with müllerian adenosarcoma.

C M Michener1, N L Simon.   

Abstract

BACKGROUND: Total abdominal hysterectomy with bilateral salpingo-oophorectomy is generally considered optimal therapy for patients with uterine sarcomas. Local resection of the tumor or hysterectomy with ovarian conservation has been used in only a small number of patients. Recurrence risk in women undergoing ovarian-sparing surgery for müllerian adenosarcomas can be difficult to evaluate due to the paucity of literature in this area. We present a reproductive-age woman with a müllerian adenosarcoma and review the literature on conservative surgical management of this class of tumors. CASE: A 25-year-old nulligravida was diagnosed with a uterine adenosarcoma and the question of conservative surgical therapy arose. Following a literature review, discussion with the patient led to the decision for ovarian preservation at the time of hysterectomy. The pelvis and abdomen were grossly free of metastatic disease at laparotomy and all tumor was confined to the uterus on pathologic examination. She is free of disease 36 months postoperatively and is now considering in vitro fertilization using a surrogate.
CONCLUSION: Ovarian conservation can probably be offered safely in carefully selected women of reproductive age with müllerian adenosarcomas. Copyright 2001 Academic Press.

Entities:  

Mesh:

Year:  2001        PMID: 11606111     DOI: 10.1006/gyno.2001.6398

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  7 in total

Review 1.  Uterine Adenosarcoma: a Review.

Authors:  Michael J Nathenson; Vinod Ravi; Nicole Fleming; Wei-Lien Wang; Anthony Conley
Journal:  Curr Oncol Rep       Date:  2016-11       Impact factor: 5.075

2.  Mullerian adenosarcoma of the cervix: Report of two large tumors with sarcomatous overgrowth or heterologous elements.

Authors:  Brandon-Luke L Seagle; Keith J Falter; Stephen J Lee; Marina Frimer; Robert Samuelson; Shohreh Shahabi
Journal:  Gynecol Oncol Case Rep       Date:  2014-05-05

3.  Feasibility of uterine preservation in the management of early-stage uterine adenosarcomas: a single institute experience.

Authors:  Young-Jae Lee; Dae-Yeon Kim; Dae-Shik Suh; Jong-Hyeok Kim; Yong-Man Kim; Young-Tak Kim; Joo-Hyun Nam
Journal:  World J Surg Oncol       Date:  2017-04-19       Impact factor: 2.754

4.  Case Report of Successful Childbearing after Conservative Surgery for Cervical Mullerian Adenosarcoma.

Authors:  Seiji Kanayama; Masako Nakamura; Hidekazu Oi; Sumire Sugimoto; Yoshikazu Sasaki; Tomoko Uchiyama; Chiho Ohbayashi; Hiroshi Kobayashi
Journal:  Case Rep Obstet Gynecol       Date:  2017-01-05

5.  Clinicopathologic characteristics and oncologic outcomes in adenosarcoma of gynecologic sites.

Authors:  Jessie Y Li; Levent Mutlu; Joan Tymon-Rosario; Wafa Khadraoui; Nupur Nagarkatti; Pei Hui; Natalia Buza; Lingeng Lu; Peter Schwartz; Gulden Menderes
Journal:  Gynecol Oncol Rep       Date:  2021-12-20

6.  Uterine mullerian adenosarcoma with sarcomatous overgrowth fatal recurrence within two weeks of diagnosis: a case report.

Authors:  Mirna H Farhat; Elie M Hobeika; Ghada Moumneh; Anwar H Nassar
Journal:  J Med Case Rep       Date:  2007-09-25

7.  Müllerian adenosarcoma of the uterine cervix with sarcomatous overgrowth: A case report of aggressive disease in a young patient.

Authors:  David A Morales F; Monica L Medina R; Lina M Trujillo; Maria I Beltrán; Isabel C Dulcey
Journal:  Int J Surg Case Rep       Date:  2016-09-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.